No Data
No Data
Weigao Blood Purification Rises 89% in Shanghai Debut
Weigao Blood Purification (603014.SH) Stocks will be listed on the Shanghai Stock Exchange Main Board on May 19.
Weigao Blood Purification (603014.SH) announces that the company's Stocks will be traded on the Shanghai Stock Exchange on May 19, 2025...
After the call-back, the final online issuance winning rate of Weigao Blood Clean (603014.SH) is 0.032%.
Weigao Blood Purification (603014.SH) announced that after the restart mechanism is initiated, the final issuance quantity for offline subscriptions is 1,251....
Weigao Blood Purification (603014.SH): The IPO issuance price is 26.50 yuan per share.
On May 6, Gelonghui announced that Weigao Blood Purification (603014.SH) revealed that the issuer and the sponsor (lead underwriter), based on the preliminary inquiry results, comprehensively assessed the company's reasonable investment value, the secondary market valuation levels of comparable companies, and the secondary market valuation levels of the Industry. Considering factors such as the effective subscription multiple of offline investors, market conditions, fundraising needs, and underwriting risks, it was mutually agreed to set the issue price at 26.50 yuan per share, with no further cumulative bidding inquiries for offline issuance. Investors are requested to subscribe online and offline at this price on May 8, 2025 (T day) without needing to make a payment at the time of subscription.
Express News | Shandong Weigao Blood Purification Products Says to Sell 41.14 Mln Shares in Shanghai Listing